Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Peringkat dalam Saham #27858
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Harga Saham
$1.00
Terakhir disinkronkan: 2023-06-01
Kapitalisasi Pasar
$30.11M
Perubahan (1 hari)
2.04%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Angion Biomedica Corp. (ANGN)

Kategori

Riwayat pemecahan saham untuk Angion Biomedica Corp. (ANGN)
Saham Angion Biomedica Corp. (simbol: ANGN) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 20, 2026.
Satu lembar saham ANGN yang dibeli sebelum Aug 20, 2026 sekarang setara dengan 0 lembar saham ANGN.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH